On December 17, Gelonghui reported that Merck announced on Monday that it has halted the development of the experimental cancer drugs vibostolimab and favezelimab after multiple trials failed when combined with the best-selling drug Keytruda to treat various cancers. Marjorie Green, head of Global Clinical Development Oncology at Merck Research, stated: "After careful analysis of the data, we have decided to stop the development of these candidate drugs to prioritize other ongoing projects."
- Headlines
- Merck announced the termination of the development of two experimental anticancer drugs.
默克宣布终止两种实验性抗癌药物的开发
Merck announced the termination of the development of two experimental anticancer drugs.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
02:09
The Exchange Rates of the Brazilian real against the US dollar have reversed the earlier downtrend and are currently up 0.3%, reaching 6.07.
02:08
Nissan: Regarding the report on potential merger negotiations with Honda, neither company has made an announcement.
02:06
The Brazilian real has risen 1% against the US dollar.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.